MET and neoplasm: Reduced levels of miR-34a were reported by northern blot in three tumor tissues compared to normal ones; miR-34a negatively regulated cell proliferation and migration by targeting MET (MET proto-oncogene, receptor tyrosine kinase) and affecting the AKT pathway [251].